卵巢交界性肿瘤(borderline ovarian tumor,BOT)与良性肿瘤和癌不同,其生物学行为介于良性与恶性肿瘤之间,约占卵巢上皮性肿瘤的10%~20%。相较于卵巢癌,BOT多发生于年轻女性,通常期别早,病程进展慢,预后好。手术已成为其主要治疗方法,多数患者要求保留生育功能,除伴浸润种植的交界性浆液性肿瘤(SBT),通常可行保留生育能力的手术。文章对近年来BOT的诊断及治疗方法等进展进行综述,以期能对临床诊疗提供一些参考。 Borderline ovarian tumor (BOT) is different from benign and malignant tumors, and its biological behavior is between benign and malignant tumors, accounting for about 10% to 20% of epithelial ovarian tumors. Compared with ovarian cancer, BOT occurred in young women, usually early, slow progression, good prognosis. Surgery has become the mainstay of treatment. Most patients require fertility maintenance. In addition to invasive serous borderline tumors (SBT), it is usually feasible to preserve fertility. In this paper, the progress of diagnosis and treatment of BOT in recent years are reviewed in order to provide some references for clinical diagnosis and treatment.